Form 4: Trulieve Cannabis Corp. CFO Wes Getman Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Wes Getman, CFO of Trulieve Cannabis Corp., was granted stock options and restricted stock units (RSUs) on March 8, 2024.
Summary
- On March 8, 2024, Wes Getman, the Chief Financial Officer of Trulieve Cannabis Corp., received a grant of 37,500 restricted stock units (RSUs).
- These RSUs represent a contingent right to receive Trulieve Cannabis Corp. subordinate voting shares.
- 50% of the RSUs will vest on December 1, 2025, and the remaining 50% will vest on December 1, 2026.
- Getman also received options to purchase 67,902 subordinate voting shares at an exercise price of $10.
- The options vest in three annual installments starting December 1, 2024.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating confidence in the company's future performance. The sentiment is neutral to positive.
Positives
- The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders.
- The vesting schedules for both the RSUs and stock options incentivize long-term performance.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.
Industry Context
Granting stock options and RSUs to executives is a common practice in the cannabis industry to attract and retain talent, and to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option and RSU grants are standard compensation practices across various industries, including the cannabis sector.
- Companies like Curaleaf, Green Thumb Industries, and Canopy Growth also utilize similar equity-based compensation plans for their executives.
- The vesting schedules and exercise prices are typically structured to incentivize long-term value creation.
Stakeholder Impact
- The grant of RSUs and stock options could positively impact shareholder value if the CFO's performance leads to increased profitability and growth.
- Employees may view the equity grants as a positive sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of transaction: Grant of RSUs and stock options. |
| 12/01/2024 | First vesting date for one-third of the stock options. |
| 12/01/2025 | First vesting date for 50% of the RSUs and second vesting date for one-third of the stock options. |
| 12/01/2026 | Second vesting date for the remaining 50% of the RSUs and third vesting date for one-third of the stock options. |
| 03/08/2031 | Expiration date of the stock options. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.